Surge in UK Home Air Conditioning Ownership Signals Shifts in Energy Demand and Consumer Behavior Gas Prices May Remain Elevated Analysts Warn of Most Volatile Summer in Years Microns Surge to 1 Trillion Market Cap Lifts US Stocks to New Highs Fed Rate Cut Prospects Dim as Jobs Data Signals Sticky Inflation LICs Valuation Cheap PE Masks Potential Expense Based on VNB Metrics Custard Apple Gains Traction as Niche Crop Despite Export Hurdles Imperial Petroleum Inc 875 Series A Preferred Shares IMPPP Q1 2026 Earnings Strong Earnings Beat Highlights Operational Efficiency VTS Q1 2026 Earnings EPS Falls Short as Operational Costs Bite BRC Group Holdings RILYZ Q1 2024 Earnings Bondholder Impact Amid No Revenue Visibility and Negative EPS Expand Energy Corporation EXE Q1 2026 Earnings Earnings Beat Driven by Operational Efficiency Stock Edges Lower DIN Q1 2026 Earnings EPS Surpasses Estimates by 529 PIMCO Access Income Fund PAXS Holds Steady as Market Awaits Direction Hudson Pacific Properties HPP Gains 14 as Office REIT Sector Shows Signs of Stabilization Envista Holdings NVST Faces Modest Pressure Near Key Support Levels Barclays BCS Posts Modest Gains as Support Level Holds Hertz Warrant HTZWW Slides 175 as Resistance Holds Firm Beyond Inc Acquires Buy Buy Baby Brand Rights Plans Reunion with Bed Bath Beyond CLGN Q4 2025 Earnings Widening Losses Yet Shares Edge Higher on Pipeline Progress Westwater Resources WWR Holds Steady Near 056 Key Levels Remain in Focus INVO Fertility Inc IVF Q3 2025 Earnings Significant EPS Miss No Revenue Reported HBANL Q1 2026 Earnings Preferred Dividend Misses Estimates on Higher Provisioning AER Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Operating Performance Northpointe Bancshares Inc NPB Q1 2026 Earnings Earnings Slightly Miss Estimates Shares Dip NU Q1 2026 Earnings EPS Misses Estimates Stock Declines on Profitability Concerns PALI Q1 2026 Earnings EPS Misses Estimates as Palisade Bio Advances Pipeline Efforts Skye Bioscience Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges